SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.66+2.8%Jan 30 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (11246)8/16/1999 9:41:00 PM
From: Bluegreen  Read Replies (3) of 17367
 
I still can't believe some think Xoma could say more than they did at this point in time! I was just thankful for the EXCELLENT results in my opinion of the Phase III Meningo. trial. I say excellent results because Xoma said it showed clinical benefit in BOTH mortality and morbidity! Now will the FDA think the clinical benefit is high enough for approval? Now that is where things get interesting and I for one am going to buy ALL I can on dips. I am betting that Castello would not say things at this point in time about clinical benefit if HE didn't think the FDA would approve it. Only my opinions. I just can't wait till tomorrow to see if I can pick up more shares on the cheap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext